This manuscript reports the use of Fourier transform ion cyclotron resonance mass spectrometry to screen a combinatorially generated natural product-based library for binding affinity to bovine carbonic anhydrase II (bCAII). The fungal natural product 3-chloro-4-hydroxyphenylacetamide was the library template, with 11 secondary amide analogues of this template constituting the combinatorial library. 2-(3-Chloro-4-hydroxyphenyl)-N-(4-sulfamoylphenethyl)acetamide (compound 11) of this library was identified as a tight binding inhibitor of bCAII, by detection of a noncovalent complex corresponding to [bCAII + 11] in the mass spectrum. A competitive bCAII enzyme binding assay validated the mass spectrometry screening result. The equilibrium dissociation constant (Ki) for 11 was measured as 77.4 nM. Preliminary structure-activity investigations of the bioactive natural product analogue are also reported.
Introduction
The relevance of natural products (NPs) to the drug discovery process is highlighted by the fact that 15 new natural product-derived drugs were launched by the pharmaceutical industry between 2000 and 2003. 1 The use of NPs as templates for construction of biologically relevant chemical libraries now represents a logical extension of the classical combinatorial library synthesis protocol. Numerous libraries incorporating a NP motif have been published 2- and several examples exist where the biological activity of a NP has been improved with small libraries that have integrated only simple functional group modifications. 8 
Davis et al.
have recently reported the isolation and structure elucidation of a new fungal natural product, 3-chloro-4-hydroxyphenylacetamide (1) (Figure 1 ). 9 A small, high-purity secondary amide library based on this NP has subsequently been reported. 10 This NP-based combinatorial library was synthesised through EDCI mediated coupling of a variety of primary amines to the commercial reagent 3-chloro-4-hydroxyphenylacetic acid (2) (Figure 1 ). This library (compounds 3-13) was added to the Eskitis Institute's chemical repository and made accessible for random biological screening ( Figure 2 ).
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The carbonic anhydrase (CA) family of Zn(II) metalloenzymes (EC 4.2.1.1) catalyses the interconversion of CO 2 and HCO 3 -, a regulatory reaction that underpins many physiological processes associated with pH control, ion transport and fluid secretion.
11,12
Classically, an aromatic or heteroaromatic sulphonamide moiety (ArSO 2 NH 2 ) is the primary recognition element for small molecules to bind the active site of CA.
Coordination of the ionised sulphonamide functional group with the active site Zn(II) of CA enables this protein:small molecule interaction.
The inhibition of CAs by aromatic sulphonamides has been exploited clinically for several decades for the treatment of a variety of conditions including glaucoma, epilepsy, bacterial infections and gastric ulcers. More recently a role for this class of compounds as anticancer agents has been identified, also as a result of CA inhibition. 13, 14 Our aim was to utilise a mixture based screening methodology that would both reveal the presence and confirm the identity, in one step, of any members from our NP-based library (3-
13)
with affinity for bCAII. The methodology adopted, bioaffinity characterization mass spectrometry (BACMS), stems from the pioneering work of Smith and co-workers. [15] [16] [17] This manuscript reports the application of this mass spectrometry screening technique, with a potent bCAII binder identified from random screening of a NP-based synthetic library. A competitive bCAII enzyme binding assay has validated the mass spectrometry screening results. Preliminary structure-activity investigations of the bioactive natural product analogue are also reported. 
Screening of the NP-based combinatorial library using ESI-FTICR-MS
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Insert Table 1 3. Screening of the NP-based library using a solution competitive binding assay 
Structure-Activity analysis of compound 11
Compound 11 was the only member of the NP-based library with affinity for bCAII. The entries in Table 1 for 1 and 2 demonstrated that the NP core template had no affinity for bCAII. Also compound 9, which lacks the sulphonamide moiety of 11, had no affinity for bCAII. Together these results indicate that it is the sulphonamide moiety that is the key bCAII recognition descriptor for 11, a conclusion consistent with literature precedent for aromatic sulphonamide moieties as the classical recognition motif for CAII.
11,12
The primary amine reagent used in the synthesis of 11 was 4-(2-aminoethyl)benzenesulphonamide (14) ( Figure   4 ). We wanted to determine if the cause of bCAII affinity for 11 was due solely to the sulphonamide component of 11 or if the NP template was acting as a secondary recognition motif alongside the sulphonamide motif of 14. The bCAII binding constants for 11 and 14 were determined, Table 2 . The bCAII affinity of the parent amine 14 is moderate (Ki = 1690 nM), while the NP derivative 11 has greater bCAII affinity (Ki = 77.4 nM). Specifically derivatization of the amine 14 with the NP scaffold to generate 11 results in a 22-fold increase in bCAII affinity. While the sulphonamide partner is necessary for binding (9 compared to 11) it is not responsible in isolation for the level of affinity for bCAII by 11. Hence we concluded that the NP template of 11 was substantially contributing to the molecular recognition for bCAII.
These results prompted us to further investigate the structure-activity relationships for the NP Table 2 . Compound 15 (-Cl only) displayed similar affinity to 11 (Ki = 66.5 nM), while 16 (-OH only) had slightly (2.3-fold) reduced affinity (Ki = 175 nM) compared to 11. Notable from this structure-activity data is that the replacement of a -Cl with a -H in the NP template leads to lessened bCAII affinity, while the replacement of an -OH with a -H has minimal affect on bCAII affinity.
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Conclusions
This work has applied bioaffinity characterization mass spectrometry (BACMS) to the analysis of a NP-based combinatorial library in the presence of the protein target bCAII. ESI-FTICR-MS was able to reveal and identify, in one step, a member from the NP-based library mixture with affinity for bCAII. This mixture-based screening strategy permitted both a rapid and informative analysis. An extension of this approach to bioactive-guided fractionation following high throughput screening of natural product extracts is possible. Therapeutic lead compounds identified by this strategy may then enter more conventional medicinal chemistry pathways for structure-activity analysis as demonstrated here. 
Procedure for ESI-FTICR-MS experiments.
The experimental results presented in this paper were performed on an APEX III 4.7 Tesla FTICR mass spectrometer (Bruker Daltonics, Billerica, MA, USA) fitted with an Apollo ESI source operated in positive ion mode. XMASS NT V7.0.2 mass spectrometry software on a PC platform was used for data acquisition. Broadband excitation was used to analyse a mass range from m/z 100 -4500, with 512 K data points acquired. Samples were infused into the ESI source at 2 Lmin -1 .
Relevant parameters include the ESI source pressure (6.2 x 10 -7 mbar), high vacuum analyser region pressure (1.3x10 -10 mbar). The drying gas temperature and capillary exit voltage were 125 ºC and 180 V, respectively for all experiments. Agilent ES tuning mix (catalogue number G2421A) was used for an external four-point calibration. 
